Stapokibart reduces blood eosinophil counts in patients with moderate-to-severe atopic dermatitis: a post-hoc analysis from phase II and phase III clinical trials

Background Eosinophils are involved in the pathogenesis of atopic dermatitis (AD).Objective This post-hoc analysis evaluated the effect of stapokibart on blood eosinophil counts in moderate-to-severe AD patients.Methods The phase II AD002 trial (n = 120) randomly assigned patients to stapokibart 300...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yan Zhao, Furen Zhang, Bin Yang, Litao Zhang, Liming Wu, Yangfeng Ding, Jinyan Wang, Yumei Li, Qingchun Diao, Jingyi Li, Qing Sun, Xiaohong Zhu, Xiaoyong Man, Lihua Wang, Yanyan Feng, Tao Cai, Huiming Zeng, Linfeng Li, Jianyun Lu, Hong Ren, Fuqiu Li, Qianjin Lu, Xiaohua Tao, Rong Xiao, Chunlei Zhang, Xiujuan Xia, Hao Cheng, Chao Ji, Wenjie Zhao, Yanping Qiu, Wei Chu, Hongyue Yan, Bo Chen, Jianzhong Zhang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2026-12-01
coleção:	Journal of Dermatological Treatment
Assuntos:	Moderate-to-severe atopic dermatitis blood eosinophil counts stapokibart
Acesso em linha:	https://www.tandfonline.com/doi/10.1080/09546634.2026.2670906
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!